360 related articles for article (PubMed ID: 18836375)
1. Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment.
Santana CA; Faber TL; Soler-Peter M; Sanyal R; Esteves FP; Ornelas M; Folks RD; Verdes L; Santana LF; Candell-Riera J; Garcia EV
Nucl Med Commun; 2008 Nov; 29(11):970-81. PubMed ID: 18836375
[TBL] [Abstract][Full Text] [Related]
2. Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch.
Stankewicz MA; Mansour CS; Eisner RL; Churchwell KB; Williams BR; Sigman SR; Streeter J; Patterson RE
J Nucl Med; 2005 Oct; 46(10):1602-9. PubMed ID: 16204709
[TBL] [Abstract][Full Text] [Related]
3. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R
Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888
[TBL] [Abstract][Full Text] [Related]
4. The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction.
Uebleis C; Hellweger S; Laubender RP; Becker A; Sohn HY; Lehner S; Haug A; Bartenstein P; Cumming P; Van Kriekinge SD; Slomka PJ; Hacker M
Int J Cardiovasc Imaging; 2013 Oct; 29(7):1645-53. PubMed ID: 23744128
[TBL] [Abstract][Full Text] [Related]
5. Incremental prognostic value of left ventricular function by myocardial ECG-gated FDG PET imaging in patients with ischemic cardiomyopathy.
Santana CA; Shaw LJ; Garcia EV; Soler-Peter M; Candell-Riera J; Grossman GB; Krawczynska EG; Faber TL; Ribera A; Vaccarino V; Halkar R; Di Carli MF
J Nucl Cardiol; 2004; 11(5):542-50. PubMed ID: 15472639
[TBL] [Abstract][Full Text] [Related]
6. The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction.
Desideri A; Cortigiani L; Christen AI; Coscarelli S; Gregori D; Zanco P; Komorovsky R; Bax JJ
J Am Coll Cardiol; 2005 Oct; 46(7):1264-9. PubMed ID: 16198841
[TBL] [Abstract][Full Text] [Related]
7. Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction.
Di Carli MF; Asgarzadie F; Schelbert HR; Brunken RC; Rokhsar S; Maddahi J
J Nucl Cardiol; 1998; 5(6):558-66. PubMed ID: 9869477
[TBL] [Abstract][Full Text] [Related]
8. Post-systolic shortening during dobutamine stress echocardiography predicts cardiac survival in patients with severe left ventricular dysfunction.
Rambaldi R; Bax JJ; Rizzello V; Biagini E; Valkema R; Roelandt JR; Poldermans D
Coron Artery Dis; 2005 May; 16(3):141-5. PubMed ID: 15818082
[TBL] [Abstract][Full Text] [Related]
9. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
[TBL] [Abstract][Full Text] [Related]
10. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.
D'Egidio G; Nichol G; Williams KA; Guo A; Garrard L; deKemp R; Ruddy TD; DaSilva J; Humen D; Gulenchyn KY; Freeman M; Racine N; Benard F; Hendry P; Beanlands RS;
JACC Cardiovasc Imaging; 2009 Sep; 2(9):1060-8. PubMed ID: 19761983
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
Zhang X; Liu XJ; Wu Q; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W
J Nucl Med; 2001 Aug; 42(8):1166-73. PubMed ID: 11483675
[TBL] [Abstract][Full Text] [Related]
12. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease.
Tio RA; Dabeshlim A; Siebelink HM; de Sutter J; Hillege HL; Zeebregts CJ; Dierckx RA; van Veldhuisen DJ; Zijlstra F; Slart RH
J Nucl Med; 2009 Feb; 50(2):214-9. PubMed ID: 19164219
[TBL] [Abstract][Full Text] [Related]
13. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular mechanical dyssynchrony analzyed by Tc-99m sestamibi SPECT and F-18 FDG PET in patients with ischemic cardiomyopathy and the prognostic value.
Tian Y; Zhao M; Li W; Zhu Z; Mi H; Li X; Zhang X
Int J Cardiovasc Imaging; 2020 Oct; 36(10):2063-2071. PubMed ID: 32495064
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
Sperry BW; Tamarappoo BK; Oldan JD; Javed O; Culver DA; Brunken R; Cerqueira MD; Hachamovitch R
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):336-345. PubMed ID: 28823747
[TBL] [Abstract][Full Text] [Related]
16. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
Wu YW; Tadamura E; Yamamuro M; Kanao S; Marui A; Tanabara K; Komeda M; Togashi K
J Nucl Med; 2007 Jul; 48(7):1096-103. PubMed ID: 17607039
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival of patients with viable and nonviable aneurysms assessed by 99mTc-MIBI SPECT and 18F-FDG PET: a comparative study of medical and surgical treatment.
Zhang X; Liu XJ; Hu S; Schindler TH; Tian Y; He ZX; Gao R; Wu Q; Wei H; Sayre JW; Schelbert HR
J Nucl Med; 2008 Aug; 49(8):1288-98. PubMed ID: 18632821
[TBL] [Abstract][Full Text] [Related]
18. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial.
Abraham A; Nichol G; Williams KA; Guo A; deKemp RA; Garrard L; Davies RA; Duchesne L; Haddad H; Chow B; DaSilva J; Beanlands RS;
J Nucl Med; 2010 Apr; 51(4):567-74. PubMed ID: 20237039
[TBL] [Abstract][Full Text] [Related]
20. Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria.
Bax JJ; Visser FC; Elhendy A; Poldermans D; Cornel JH; van Lingen A; Boersma E; Sloof GW; Fioretti PM; Visser CA
J Nucl Med; 1999 Nov; 40(11):1866-73. PubMed ID: 10565782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
